{
  "denotations": [
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 23,
        "end": 34
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 106,
        "end": 112
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 191,
        "end": 195
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 217,
        "end": 221
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 234,
        "end": 244
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 67,
        "end": 71
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23569304_9",
  "text": "Acquired resistance to vemurafenib associated with reactivation of MAPK signaling as observed by elevated ERK1/2 phosphorylation levels in progressive lesions and the appearance of secondary NRAS ( Q61 ) mutations or MEK1 ( Q56P ) or MEK1(E203K ) mutations ."
}
